Published in Lancet on May 03, 1980
Breast cancer trials--a new initiative. Br Med J (1980) 0.75
Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med (1997) 10.83
Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet (1999) 8.44
Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med (2001) 6.27
ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders. Sarcoidosis Vasc Diffuse Lung Dis (1999) 3.69
Randomized study of initial versus late chest irradiation combined with chemotherapy in limited-stage small-cell lung cancer. Aarhus Lung Cancer Group. J Clin Oncol (1997) 3.45
Factors influencing the effect of age on prognosis in breast cancer: population based study. BMJ (2000) 2.80
Tamoxifen in advanced breast cancer. Cancer Treat Rev (1978) 2.53
Paroxysmal nocturnal haemoglobinuria: long-term follow-up and prognostic factors. French Society of Haematology. Lancet (1996) 2.41
Patient's and doctor's delay in primary breast cancer. Prognostic implications. Acta Oncol (1994) 2.27
[Improved prognosis of breast cancer]. Ugeskr Laeger (1994) 2.21
Performance status assessment in cancer patients. An inter-observer variability study. Br J Cancer (1993) 2.15
Randomised controlled trial of a shared care programme for newly referred cancer patients: bridging the gap between general practice and hospital. Qual Saf Health Care (2003) 2.07
Danish randomized trial comparing breast conservation therapy with mastectomy: six years of life-table analysis. Danish Breast Cancer Cooperative Group. J Natl Cancer Inst Monogr (1992) 1.93
High levels of urokinase-type plasminogen activator and its inhibitor PAI-1 in cytosolic extracts of breast carcinomas are associated with poor prognosis. Cancer Res (1993) 1.86
The Nottingham Prognostic Index applied to 9,149 patients from the studies of the Danish Breast Cancer Cooperative Group (DBCG). Breast Cancer Res Treat (1994) 1.69
Familial aggregation of sarcoidosis. A case-control etiologic study of sarcoidosis (ACCESS). Am J Respir Crit Care Med (2001) 1.68
Evidence of a castration-mediated effect of adjuvant cytotoxic chemotherapy in premenopausal breast cancer. J Clin Oncol (1987) 1.59
Adjuvant chemotherapy plus tamoxifen compared with tamoxifen alone for postmenopausal breast cancer: meta-analysis of quality-adjusted survival. Lancet (1996) 1.58
Tamoxifen in high-risk premenopausal women with primary breast cancer receiving adjuvant chemotherapy. Report from the Danish Breast Cancer co-operative Group DBCG 82B Trial. Eur J Cancer (1999) 1.55
Frequency and genome load of Epstein-Barr virus in 509 breast cancers from different geographical areas. Br J Cancer (2001) 1.55
Cyclophosphamide versus ifosfamide: final report of a randomized phase II trial in adult soft tissue sarcomas. Eur J Cancer Clin Oncol (1987) 1.53
Prognostic value of steroid hormone receptors: multivariate analysis of systemically untreated patients with node negative primary breast cancer. Cancer Res (1987) 1.53
Acquisition of nicotine self-administration in rats: the effects of dose, feeding schedule, and drug contingency. Psychopharmacology (Berl) (1998) 1.50
Association between high concentrations of Mr 52,000 cathepsin D and poor prognosis in primary human breast cancer. Cancer Res (1989) 1.48
[Spontaneous remission of breast cancer. A literature review]. Ugeskr Laeger (1999) 1.48
Personality styles of patients asserting environmental illness. J Occup Med (1990) 1.44
Adjuvant chemotherapy for premenopausal breast cancer: a meta-analysis using quality-adjusted survival. Cancer J Sci Am (2006) 1.43
The impact of pancreas transplantation on kidney allograft survival. Am J Transplant (2011) 1.42
Results of randomised studies of the EORTC Soft Tissue and Bone Sarcoma Group (STBSG) with two different ifosfamide regimens in first- and second-line chemotherapy in advanced soft tissue sarcoma patients. Eur J Cancer (2002) 1.41
[Use of Q10 in cancer patients]. Ugeskr Laeger (1994) 1.39
Radiation-induced brachial plexopathy: neurological follow-up in 161 recurrence-free breast cancer patients. Int J Radiat Oncol Biol Phys (1993) 1.38
[Treatment of primary breast cancer. Consequences of mammographic screening in the municipality of Copenhagen]. Ugeskr Laeger (1996) 1.38
[Chemotherapy in metastasing breast cancer--is it beneficial?]. Ugeskr Laeger (1994) 1.38
The importance of surgery and accurate axillary staging for survival in breast cancer. Eur J Surg Oncol (1998) 1.37
Nephrectomy after transplant failure: current practice and outcomes. Am J Transplant (2007) 1.31
Molecular characterization of the idiopathic hypereosinophilic syndrome (HES) in 35 French patients with normal conventional cytogenetics. Leukemia (2005) 1.27
Should women be advised against pregnancy after breast-cancer treatment? Lancet (1997) 1.26
A comparison of synchronization filters in different auditory receptor organs. Hear Res (1988) 1.24
Prognostic usefulness of estrogen receptor immunocytochemical assays for human breast cancer. Cancer Res (1986) 1.23
Microvessel density compared with the Chalkley count in a prognostic study of angiogenesis in breast cancer patients. Histopathology (2004) 1.21
Danish Breast Cancer Cooperative Group (DBCG). A description of the register of the nation-wide programme for primary breast cancer. Acta Oncol (1988) 1.21
Income of living kidney donors and the income difference between living kidney donors and their recipients in the United States. Am J Transplant (2012) 1.20
[Mammographic examinations in Denmark, 1990-1991]. Ugeskr Laeger (1994) 1.19
Axillary dissection of level I and II lymph nodes is important in breast cancer classification. The Danish Breast Cancer Cooperative Group (DBCG). Eur J Cancer (1992) 1.18
Incidence of new primary cancers after adjuvant tamoxifen therapy and radiotherapy for early breast cancer. J Natl Cancer Inst (1991) 1.18
Attention-Deficit Hyperactivity Disorder (ADHD) symptoms and smoking patterns among participants in a smoking-cessation program. Nicotine Tob Res (2001) 1.15
The biotransformation of cyclophosphamide in man: analysis of the variation in normal subjects. Acta Pharmacol Toxicol (Copenh) (1974) 1.15
Properties and regional distribution of histidine decarboxylase in rat brain. J Neurochem (1970) 1.15
The prognostic value of angiogenesis by Chalkley counting in a confirmatory study design on 836 breast cancer patients. Clin Cancer Res (2000) 1.14
Time since childbirth and prognosis in primary breast cancer: population based study. BMJ (1997) 1.13
Establishment of a new human pneumococcal standard reference serum, 007sp. Clin Vaccine Immunol (2011) 1.11
Oral clodronate in breast cancer patients with bone metastases: a randomized study. J Intern Med (1999) 1.10
The neurological manifestations of Gaucher disease type 1: the French Observatoire on Gaucher disease (FROG). J Inherit Metab Dis (2010) 1.10
Prognostic factors in primary mucinous breast carcinoma. Am J Clin Pathol (1987) 1.10
Parity, age at first childbirth and the prognosis of primary breast cancer. Br J Cancer (1998) 1.10
Adjuvant radiotherapy and risk of contralateral breast cancer. J Natl Cancer Inst (1992) 1.10
Systemic cytotoxic therapy of basal cell carcinoma. A review of the literature. Eur J Cancer (1990) 1.09
Angiogenesis in breast cancer: a comparative study of the observer variability of methods for determining microvessel density. Lab Invest (1998) 1.08
Tamoxifen and bone metabolism in postmenopausal low-risk breast cancer patients: a randomized study. J Clin Oncol (1994) 1.06
Danish Breast Cancer Cooperative Group (DBCG). Structure and results of the organization. Acta Oncol (1988) 1.05
Controversies in hypersensitivity pneumonitis. Am Rev Respir Dis (1992) 1.05
JAK2V617F-positive polycythemia vera and Philadelphia chromosome-positive chronic myeloid leukemia: one patient with two distinct myeloproliferative disorders. Leukemia (2008) 1.04
In vivo occupation of cerebral histamine H1-receptors evaluated with 3H-mepyramine may predict sedative properties of psychotropic drugs. Eur J Pharmacol (1979) 1.04
Grading of soft tissue sarcomas: experience of the EORTC Soft Tissue and Bone Sarcoma Group. Eur J Cancer (1993) 1.03
Second cancer following cancer of the female breast in Denmark, 1943-80. Natl Cancer Inst Monogr (1985) 1.03
Histopathological characteristics and oestrogen receptor content in primary breast carcinoma. Virchows Arch A Pathol Anat Histol (1981) 1.03
Role of manganese in the pathogenesis of portal-systemic encephalopathy. Metab Brain Dis (1998) 1.03
Mitoxantrone for the treatment of advanced breast cancer: single-agent therapy in previously untreated patients. Eur J Cancer Clin Oncol (1984) 1.03
Medullary carcinoma of the breast. Prevalence and prognostic importance of classical risk factors in breast cancer. Eur J Cancer (1995) 1.03
The prognostic value of immunohistochemical estrogen receptor analysis in paraffin-embedded and frozen sections versus that of steroid-binding assays. Eur J Cancer (1990) 1.02
Can the survival difference between breast cancer patients in Denmark and Sweden 1989 and 1994 be explained by patho-anatomical variables?--a population-based study. Eur J Cancer (2004) 1.02
The effect of tamoxifen on bone mineral content in premenopausal women with breast cancer. Cancer (1984) 1.02
Therapeutic effect of tamoxifen alone versus tamoxifen in combination wtih gestagen and oestrogen in advanced breast cancer. Recent Results Cancer Res (1980) 1.02
Detection of antibodies to the recombinant P39 protein of Borrelia burgdorferi using enzyme immunoassay and immunoblotting. J Rheumatol (1993) 1.01
Inter- and intraobserver variability in the histopathological diagnosis of medullary carcinoma of the breast, and its prognostic implications. Breast Cancer Res Treat (1989) 1.01
Prognostic significance of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in primary breast cancer. Br J Cancer (1998) 1.01
Radiation-induced brachial plexus neuropathy in breast cancer patients. Acta Oncol (1990) 1.01
A DICEPHALOUS FOETUS. Can Med Assoc J (1927) 1.01
Subcutaneous panniculitis-like T-cell lymphoma during pregnancy with successful autologous stem cell transplantation. Ann Hematol (2003) 1.01
Organisation of the Danish adjuvant trials in breast cancer. Dan Med Bull (1981) 1.01
Metastatic pattern in recurrent breast cancer. Special reference to intrathoracic recurrences. Cancer (1988) 1.01
Effects of an insertion mutation in a locus affecting pyridine nucleotide transhydrogenase (pnt::Tn5) on the growth of Escherichia coli. J Bacteriol (1980) 1.01
Differential effects of response-contingent and response-independent nicotine in rats. Eur J Pharmacol (2000) 1.00
Isolation and partial characterization of a mutant of Escherichia coli lacking pyridine nucleotide transhydrogenase. Arch Biochem Biophys (1978) 0.99
Anxiety and depression in breast cancer patients at low risk of recurrence compared with the general population: a valid comparison? J Clin Epidemiol (1999) 0.99
The pattern of metastases in human breast cancer. Influence of systemic adjuvant therapy and impact on survival. Acta Oncol (1988) 0.98
The effect of finger millet feeding on the early responses during the process of wound healing in diabetic rats. Biochim Biophys Acta (2004) 0.98
Lack of prognostic significance of epidermal growth factor receptor and the oncoprotein p185HER-2 in patients with systemically untreated non-small-cell lung cancer: an immunohistochemical study on cryosections. Br J Cancer (1996) 0.97